(TBRG) TruBridge - Ratings and Ratios

TruBridge, Inc. (NASDAQ:TBRG) is a healthcare technology company that provides a comprehensive suite of solutions and services to community hospitals, clinics, and healthcare systems in the US and internationally. The companys two main segments, Financial Health and Patient Care, are designed to optimize revenue cycle management, analytics, and business intelligence for healthcare providers. By leveraging its expertise in RCM, TruBridge helps care settings streamline their financial operations, improve patient engagement, and enhance overall clinical outcomes.

The companys extensive range of services includes patient liability estimation, eligibility verification, claim scrubbing, remittance management, and denial/audit management, as well as RCM services such as accounts receivable management, medical coding, and revenue cycle consulting. Additionally, TruBridge offers acute care software systems, managed IT services, and encoder solutions, providing a holistic approach to healthcare technology. Its innovative solutions, such as InstantPHR and CHBase, enable healthcare organizations to better manage patient data and improve care coordination.

From a technical analysis perspective, TBRGs stock price has shown significant volatility, with an Average True Range (ATR) of 1.34, representing a 5.40% daily price swing. The stock is currently trading below its 20-day and 50-day Simple Moving Averages (SMA), indicating a potential downtrend. However, the stocks 200-day SMA suggests a longer-term uptrend. Given the current price of $24.81, a potential support level is seen at the 52-week low of $8.41, while resistance is likely to be encountered at the 52-week high of $30.09.

Fundamentally, TruBridges market capitalization stands at $393.02M, with a forward Price-to-Earnings (P/E) ratio of 9.81, indicating a relatively reasonable valuation. However, the companys Return on Equity (RoE) is currently negative at -11.40%, suggesting that the company is not generating profits for its shareholders. Considering the technical and fundamental data, a forecast for TBRGs stock price could be made. If the company can improve its profitability and RoE, and the stock price can break above the 50-day SMA, it may be poised for a rally towards the 52-week high. Conversely, if the downtrend continues, the stock may retest the 52-week low. A potential price target could be around $28-$30, representing a 12-20% upside from current levels, assuming the company can demonstrate improved financial performance and the technical indicators turn positive.